Research Solutions, Inc.: Form 10-Q for the period ended Mar 31, 2021
Filed with the SEC on May 13, 2021 and accepted by EDGAR at May 13, 2021, 20:27 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-01-01 to 2021-03-31 | $8.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2020-07-01 to 2021-03-31 | $23.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-01-01 to 2021-03-31 | $5.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2020-07-01 to 2021-03-31 | $16.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-01-01 to 2021-03-31 | $2.7m | us-gaap:GrossProfit |
| Gross profit | 9 months2020-07-01 to 2021-03-31 | $7.5m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2021-01-01 to 2021-03-31 | $2.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-07-01 to 2021-03-31 | $7.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-01-01 to 2021-03-31 | $50.1k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-07-01 to 2021-03-31 | −$194.0k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2021-01-01 to 2021-03-31 | $572 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-07-01 to 2021-03-31 | $3.1k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-01-01 to 2021-03-31 | $49.7k | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-07-01 to 2021-03-31 | −$196.2k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-01-01 to 2021-03-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-07-01 to 2021-03-31 | −$0.01 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-01-01 to 2021-03-31 | $0.00 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-07-01 to 2021-03-31 | −$0.01 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-01-01 to 2021-03-31 | 26,565,892 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-07-01 to 2021-03-31 | 25,966,072 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-07-01 to 2021-03-31 | $2.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-07-01 to 2021-03-31 | $11.9k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2020-07-01 to 2021-03-31 | $150.4k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-03-31 | $11.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-03-31 | $17.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-03-31 | $17.3m | us-gaap:Assets |
| Current liabilities | At period end2021-03-31 | $12.2m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2021-03-31 | $5.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001558370-21-007086. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.